Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10066	Companies
205769	Keywords
136026	Articles
109100	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 02/04/2025 at 05:36, 1 year 1 month ago

Onco-Innovations Completes Acquisition of Inka Health to Accelerate AI-Driven Cancer Research and Drug Development
Onco-Innovations Limited completes acquisition of Inka Health Corp, a Canadian-based software company pioneering AI-driven analytics in cancer research and drug development. Strengthens precision oncology capabilities

Acquisition AI Technology Precision Oncology Onco-Innovations Inka Health
BRIEF

published on 01/30/2025 at 23:05, 1 year 1 month ago

Onco-Innovations' PNKP Inhibitors Display Potential in Cancer Therapy

Cancer Therapy Drug Resistance PNKP Inhibitors DNA Repair Chemo Enhancement
BRIEF

published on 01/30/2025 at 23:05, 1 year 1 month ago

Les inhibiteurs PNKP d'Onco-Innovations présentent un potentiel dans le traitement du cancer

Thérapie Contre Le Cancer Inhibiteurs De La PNKP Réparation De L'ADN Résistance Aux Médicaments Amélioration De La Chimio
PRESS RELEASE

published on 01/30/2025 at 23:00, 1 year 1 month ago

Onco-Innovations' Licensed Technology Shows Promise in Enhancing Chemotherapy Effectiveness by Overcoming Cancer Cell Resistance and Inhibiting Cancer Cell Repair
Onco-Innovations announces breakthrough Technology enhancing cancer treatment efficacy by inhibiting DNA repair in cancer cells, potentially improving patient outcomes in a multi-billion-dollar market

Patient Outcomes Cancer Treatment Onco-Innovations DNA Repair Inhibitors Cancer Therapy Market
BRIEF

published on 01/29/2025 at 22:50, 1 year 1 month ago

Onco-Innovations' Private Placement Fully Subscribed

Private Placement Securities Market Confidence Onco-Innovations Fully Subscribed
BRIEF

published on 01/29/2025 at 22:50, 1 year 1 month ago

Le placement privé d'Onco-Innovations est entièrement souscrit

Placement Privé Titres Confiance Du Marché Innovations Oncologiques Entièrement Abonné
PRESS RELEASE

published on 01/29/2025 at 22:45, 1 year 1 month ago

Onco-Innovations' Private Placement Fully Subscribed
Onco-Innovations Limited announces the full subscription of its non-brokered private placement, closing soon. Investors show strong confidence in the company's vision and mission in cancer research and treatment

Private Placement Investors Closing Date Cancer Research Onco-Innovations Limited
BRIEF

published on 01/24/2025 at 17:20, 1 year 1 month ago

Onco-Innovations Reports No Material Changes Amid Market Activity

Forward-looking Statements Cancer Research Market Activity Onco-Innovations Material Change
BRIEF

published on 01/24/2025 at 17:20, 1 year 1 month ago

Onco-Innovations ne signale aucun changement important malgré l'activité du marché

Énoncés Prospectifs Activité Du Marché Recherche Sur Le Cancer Innovations Oncologiques Changement De Matériau
PRESS RELEASE

published on 01/24/2025 at 17:15, 1 year 1 month ago

Onco-Innovations Unaware of Any Material Change
Onco-Innovations Limited addresses recent market activity, confirming no material changes. The Canadian company focuses on cancer research and treatment with innovative therapies

Innovative Solutions Cancer Research Market Activity Canadian Company Onco-Innovations Limited

Accesswire

Published on 03/23/2026 at 14:05, 1 hour 9 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 1 hour 14 minutes ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 2 hours 9 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 2 hours 42 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 2 hours 44 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 15:05, 8 minutes ago

Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 32 minutes ago

CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 43 minutes ago

Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 44 minutes ago

Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 14:24, 49 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Les Echos

Published on 03/23/2026 at 08:10, 7 hours 4 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 20 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 20 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 20 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 20 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE